Zenflow
A minimally invasive implant system designed to relieve urinary symptoms caused by an enlarged prostate.
$52MSeries D
ParticipantC
ClavystBio
Activity from announced rounds
Activity in this selectionOct 16, 2026 · Sep 17, 2026
- Rounds participated in
- 1
- Confirmed lead rounds
- 0 All roles disclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $52M 1 disclosed · full round size, not this investor’s share